TrumpRx GLP-1 Prices: What Wegovy, Ozempic, Zepbound and Foundayo Cost

TrumpRx saves you nothing on a GLP‑1. It is a free government price board, not a pharmacy, and every GLP‑1 figure on it is the drugmaker’s own self-pay price. In October 2026 the cheapest GLP‑1 listing is the Wegovy pill’s lowest dose at $149 a month.^[3] Both semaglutide pens, Wegovy and Ozempic, open at $199 for two months and then cost $349,^[2] Zepbound runs $299 to $449,^[5] and Foundayo sits between $149 and $299.^[7] Each of those matches, dose for dose, what NovoCare and LillyDirect charge when you go to them directly.^[12][14][15] So TrumpRx does not beat the alternatives; it points to them. It is cash only, and the money does not count toward an insurance deductible. Two groups can do better: Medicare Part D enrollees who qualify for the GLP‑1 Bridge pay $50 a month,^[17] and people whose commercial plan covers the drug can pay as little as $25 with a manufacturer card.^[12][15]

A price board, not a pharmacy

The site traces back to November 6, 2025, when Eli Lilly and Novo Nordisk each signed a most-favored-nation pricing deal at the White House. That announcement promised Wegovy and Ozempic at $350 a month, Zepbound and the then-unapproved orforglipron at an average of $346, and $150 for the starting dose of a GLP‑1 pill.^[9] Launch day was February 5, 2026, and five companies were on it at the start: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer.^[10] A May 2026 expansion brought in over 600 generics, kept in their own section apart from the branded deals.^[11]

The site describes itself as a list of discounted prices, not a store. Its own answers say it “does not sell or dispense drugs,” that no account is needed, and that it is free to use.^[1] Medicare’s consumer page puts it more bluntly: “You can’t buy drugs directly from TrumpRx.”^[17] What you get from it is one of two things, depending on the drug:

• A coupon for a retail pharmacy. The Novo Nordisk drugs (Wegovy pen and pill, Ozempic pen and pill) come with a coupon card, with a BIN, PCN, group and member number, that you hand to the pharmacy with your prescription.^[2][3][4]
• A link to the manufacturer. Zepbound, Foundayo and Mounjaro send you to LillyDirect, Lilly’s direct-to-patient service, which handles eligibility and delivery. TrumpRx says Lilly “manages all Zepbound (Tirzepatide) Vial orders through LillyDirect.”^[5][7][8]

Either way you still need a valid prescription from a clinician. TrumpRx does not prescribe and does not connect you to a prescriber.^[1]

So the prescription has to come from somewhere else, and some telehealth services write brand-name prescriptions while leaving the drug to be paid for separately. QuickMD sells a single doctor consultation, by video or phone, and sends the prescription to your own pharmacy, where you pay for the medication. Maven Clinic charges a membership for clinician visits and coaching, with the drug billed by the pharmacy at the manufacturer’s self-pay price, and Wisp lists a weight care consult fee for Zepbound, with the medication billed separately by your pharmacy.

AgelessRx splits the bill the same way for the Wegovy pen: NovoCare bills you for the pen, and AgelessRx charges its own monthly monitoring fee on top.

Others wrap the prescription in a program. Calibrate Health’s Metabolic Reset uses branded drugs only, billed apart from its program fee, and Modern Age, a New York longevity clinic, has its partner pharmacy bill the drug and try your insurance. Noom lists brand tirzepatide in its GLP-1Rx program. Elevated Health and Gala carry branded Ozempic on the same menu as their compounded semaglutide and tirzepatide.

Every GLP-1 on TrumpRx and its price, October 2026

The homepage shows one headline figure per drug, which is always the cheapest dose. The product pages break the price out by strength, and that is where the real cost sits.^[1]

Every row comes from that product’s own TrumpRx page: Wegovy pen,^[2] Wegovy pill,^[3] Ozempic pen,^[4] Ozempic pill,^[19] Zepbound vial,^[5] Zepbound KwikPen,^[6] Foundayo^[7] and Mounjaro.^[8] Not all of these are weight-loss brands. Mounjaro is the same molecule as Zepbound but is labeled for type 2 diabetes, as is the Ozempic pen; our brand-name map sorts out which is which. The site also lists Trulicity at $389 a month and a generic liraglutide (the Victoza molecule) priced by local pharmacy through discount aggregators.^[20][21]

Three details on those pages decide what you pay:

• The $199 pen price is two fills only. Only new patients get it, only on the two lowest strengths (0.25 mg, 0.5 mg), only for two months, and only between November 17, 2025 and December 31, 2026. Every fill after that is $349 or more.^[2][4]
• Lilly’s higher doses depend on refilling on time. The $449 Zepbound price on 7.5 mg and up holds only when the next order lands within 45 days of the previous delivery. Go past 45 days and 7.5 mg costs $499, while 10, 12.5 and 15 mg each cost $699. Foundayo’s top two doses go from $299 to $349 on the same rule.^[5][7]
• Some Foundayo prices are temporary. Foundayo’s 2.5 mg and 5.5 mg strengths carry a discount that lapses on December 31, 2026; TrumpRx lists their normal prices as $199 and $299.^[7]

The “original price” column is where the large percentage-off banners come from. For most products it is close to the list price, the figure insurers are billed before discounts. For the Zepbound KwikPen it is not: the comparison figure TrumpRx shows there is $499 to $699, which is Lilly’s own regular self-pay price for the pen.^[6][15] Cash buyers going to the manufacturers were already paying the self-pay prices, not list, so the “70% to 85% off” banners measure the gap from a number most of them never paid.

TrumpRx against NovoCare and LillyDirect

Before TrumpRx existed, Novo Nordisk sold Wegovy and Ozempic for cash through its NovoCare Pharmacy and savings offers, and Lilly sold Zepbound and later Foundayo through LillyDirect. Read on the same day, the manufacturers’ own pages give the same numbers TrumpRx does.

Manufacturer sources: NovoCare’s Wegovy and Ozempic savings pages,^[12][13] LillyDirect’s Foundayo page^[14] and Lilly’s Zepbound savings page, which applies the $299 starting price to a one-month supply whether that comes as a KwikPen or as four vials.^[15] The Novo coupon on TrumpRx is literally the Novo self-pay offer: its terms tell you to describe the purchase to your insurer as made “using the Wegovy self-pay offer.”^[2] The Lilly products on TrumpRx link straight to LillyDirect.^[5]

For GLP‑1s, then, TrumpRx is a government-run price board for deals the manufacturers also offer on their own sites. It helps with convenience, since the Novo coupon is presented at a retail pharmacy and a single page shows every dose. It does not find you a lower price than going to Novo or Lilly directly. Our guides to semaglutide without insurance and the cheapest cash routes overall reached the same conclusion from the other direction.

Did the deal deliver what was announced? Roughly. The November 2025 promise was $350 for Wegovy and Ozempic and an average of $346 for Zepbound.^[9] The launch fact sheet restated those as averages, with floors of $199 for the Novo pens, $149 for the Wegovy pill and $299 for Zepbound.^[10] The listings above match those floors. At the doses most people stay on, the pens cost $349 and Zepbound $449, not the headline figure.

What a year costs at the maintenance price

Starting doses are cheap and short. The number that matters for a household budget is twelve months at the dose you end up on. At TrumpRx prices, using the listed maintenance-dose figure for every month:

Monthly figures come from the TrumpRx product pages^[2][5] and the Bridge copay from CMS.^[16] The gap between on-time and late Zepbound refills, $3,000 a year at the top dose, is larger than any difference between TrumpRx and any other legitimate brand-name source. Our article on Wegovy HD covers whether the higher dose is worth the extra $50 a month.

Who can use TrumpRx prices

The coupon terms on the Novo pages set the conditions: you must be paying cash, be 18 or older, live in the United States or a U.S. territory, and hold a valid prescription for the drug.^[2] Lilly’s products carry their own eligibility checks at LillyDirect.^[5]

If you have commercial insurance, you can still pay the TrumpRx price, but the purchase sits entirely outside your plan. TrumpRx’s FAQ limits its prices to people paying cash and tells insured readers to weigh them against their plan’s price.^[1] The coupon terms say you cannot count the cost toward your deductible or out-of-pocket limit and cannot ask the plan to reimburse you.^[2] For someone in a high-deductible plan, that means a year of cash fills leaves the deductible untouched.

If you have Medicare, Medicaid, VA care or TRICARE, the pages disagree with each other. The Wegovy pen and Ozempic coupon terms address people on those programs and require them not to claim the cost, which implies they may use it.^[2][4] Novo’s own savings page says government-insured patients “are able to pay the self-pay price.”^[12] But the TrumpRx page for the Wegovy pill says “Government beneficiaries excluded.”^[3] If you are on a government plan and want the pill at the TrumpRx price, ask the pharmacy whether the coupon will run before you rely on it. For most Medicare enrollees with obesity, the better question is whether they qualify for the Bridge.

Medicare: the GLP-1 Bridge beats TrumpRx for those who qualify

Since July 1, 2026, Medicare has run a short-term program called the Medicare GLP‑1 Bridge that gives eligible Part D enrollees certain GLP‑1 drugs for a $50 monthly copay. It runs through December 31, 2027.^[16] The covered drugs are Foundayo, Wegovy (pen or pill) and the Zepbound KwikPen; Zepbound vials and single-dose pens are not covered.^[17] Lilly fills its share of Bridge prescriptions through LillyDirect at the same $50.^[18]

Getting in depends on BMI plus diagnoses. Medicare.gov sets three tiers:^[17]

• BMI 35 or higher, with nothing else required.
• BMI 30 or higher plus one of: chronic kidney disease at stage 3a or beyond, uncontrolled blood pressure, or HFpEF (the form of heart failure where the pumping fraction is preserved).
• BMI 27 or higher plus one of: peripheral artery disease that causes symptoms, a past stroke or heart attack, or prediabetes.

The Bridge turns away anyone already getting a GLP‑1 through Part D. It also turns away people whose diagnosis list includes fatty liver disease, sleep apnea that is moderate or worse, or type 2 diabetes, since their regular plan may pay for the drug on those grounds.^[17] The $50 does not count toward Part D out-of-pocket costs and no low-income subsidy applies.^[16]

For anyone who qualifies, $50 is a sixth or less of the cheapest maintenance price on TrumpRx. Medicare itself sends people who fail its eligibility questions to TrumpRx, with a warning that discount cards “aren’t considered creditable coverage” and that what you spend with them does not count toward your Medicare deductible or out-of-pocket maximum.^[17] Our Medicare GLP‑1 Bridge guide walks through the prior authorization.

Commercial insurance: check the copay first

Every TrumpRx GLP‑1 page carries the same line: “If you have insurance, check your co-pay first—it may be even lower.”^[2] For people whose plan covers the drug, that is usually right. With a covered plan, Novo’s Wegovy card can cut the copay to $25, though it pays no more than $100 of savings in any month.^[12] Lilly’s Zepbound card works the same way at $25, up to $1,300 in savings a year.^[15] Where a plan covers the drug, those cards beat every TrumpRx price. Where the plan refuses, the cash price is the fallback and TrumpRx and the manufacturer quote the same number. Our guide to getting a GLP‑1 covered covers the appeal route.

Does TrumpRx beat the alternatives?

Sources: TrumpRx, NovoCare, Lilly and Medicare pages above.^{[1][12][15][17]} One thing the table leaves out is compounded semaglutide and tirzepatide from telehealth sellers, which often cost less per month than any brand-name price here. They are not FDA-approved products and are not on TrumpRx; our cash-price guide covers that market and its risks, and the price tracker lists current seller prices.

What changes after December 31, 2026

Several prices on TrumpRx carry an end date. The $199 introductory fills for the Wegovy and Ozempic pens run only through December 31, 2026, and NovoCare’s Wegovy page says its pricing will be updated after that date.^[2][12] Foundayo’s reduced 2.5 mg and 5.5 mg prices end the same day.^[7][14] Lilly’s commercial copay card for Zepbound also expires at the end of the year.^[15] No replacement prices had been posted as of October 17, 2026. Because TrumpRx simply displays the manufacturers’ offers, whatever Novo and Lilly set for 2027 is what TrumpRx will show.